Epilepsy Center Fundraiser Bullish on Wine
CINCINNATIJon Zipperstein, Susan Muth and Michael Privitera, MD, will host Innovations in Epilepsy Research from 6 to 8:30 p.m. Sunday, Oct. 26, at Embers Restaurant in Madeira. The second annual event will raise funds for epilepsy research at the Epilepsy Center at the University of Cincinnati (UC) Neuroscience Institute.
The event will showcase a sommeliers tasting room filled with rare and extravagant wines that one rarely gets a chance to taste, Muth says. The event also will feature guest bartenders, heavy hors doeuvres and a silent auction of fine wines, vacation and golf packages and gifts. Matthew Citriglia, a Level IV master sommelier, will head up the tasting room and answer guests questions about wine.
Zipperstein, owner of Embers, is a resident of Montgomery; Muth, founder of Strategic Business Solutions, Inc., is a resident of Indian Hill; and Privitera, director of the Epilepsy Center and professor of neurology, is a resident of Clifton.
Privitera says that the still-expanding auction, which offers a wide range of winesfrom $20 bottles to a 1989 Haut Brion valued at $1,220is definitely shaping up to be the best wine auction I have ever seen in this region.
Tickets are $50 per person. For reservations and information, contact Jennifer Dilbert of the UC Foundation at (513) 558-6903 or Jennifer.Dilbert@uc.edu.
The events platinum sponsor is American Financial Group; gold sponsors are Greenebaum, Doll & McDonald, Carespring Health Care Management, and Edyth Lindner. Embers restaurant is donating the use of the entire restaurant and all of the food.
The Epilepsy Center, identified as a center of excellence by the National Association of Epilepsy Centers, cares for more epilepsy patients than any other center in the region and includes the regions only Level IV epilepsy monitoring unit. The comprehensive program includes detailed evaluation, coordinated medical and surgical treatment, and clinical trials that make the newest therapies available to patients. It is known internationally for its role in developing new seizure medications and for its work in brain imaging.
The UC Neuroscience Institute, a regional center of excellence at University Hospital and the UC College of Medicine, is dedicated to patient care, research, education and the development of new treatments for stroke, brain and spinal tumors, epilepsy, multiple sclerosis, traumatic brain and spinal injury, Alzheimers disease, Parkinsons disease, disorders of the senses (swallowing, voice, hearing, pain, taste and smell) and psychiatric conditions (bipolar disorder, schizophrenia and depression).
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.